Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
HCAT

HCAT - Health Catalyst Inc Stock Price, Fair Value and News

6.32USD-0.36 (-5.39%)Market Closed

Market Summary

HCAT
USD6.32-0.36
Market Closed
-5.39%

HCAT Alerts

  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

HCAT Stock Price

View Fullscreen

HCAT RSI Chart

HCAT Valuation

Market Cap

373.1M

Price/Earnings (Trailing)

-3.54

Price/Sales (Trailing)

1.26

Price/Free Cashflow

-20.44

HCAT Price/Sales (Trailing)

HCAT Profitability

Return on Equity

-29.55%

Return on Assets

-15.18%

Free Cashflow Yield

-4.89%

HCAT Fundamentals

HCAT Revenue

Revenue (TTM)

296.8M

Rev. Growth (Yr)

1.16%

Rev. Growth (Qtr)

-0.48%

HCAT Earnings

Earnings (TTM)

-105.5M

Earnings Growth (Yr)

37.97%

Earnings Growth (Qtr)

32.08%

Breaking Down HCAT Revenue

Last 7 days

-4.5%

Last 30 days

-7.6%

Last 90 days

-19.2%

Trailing 12 Months

-46.3%

How does HCAT drawdown profile look like?

HCAT Financial Health

Current Ratio

4.31

Debt/Equity

0.64

Debt/Cashflow

-0.08

HCAT Investor Care

Shares Dilution (1Y)

4.93%

Diluted EPS (TTM)

-1.84

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024296.8M000
2023282.0M284.6M290.0M295.9M
2022254.2M265.2M271.8M276.2M
2021199.6M215.9M230.5M241.9M
2020164.8M171.3M179.1M188.8M
2019127.2M141.0M147.5M154.9M
2018086.2M99.4M112.6M
201700073.1M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Health Catalyst Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 11, 2024
freeman kevin lee
sold
-49,008
6.5344
-7,500
chief commercial officer
Jun 06, 2024
lesueur daniel
sold
-80,064
6.7151
-11,923
chief operating officer
Jun 06, 2024
landry benjamin
sold
-16,018
6.7105
-2,387
general counsel
Jun 03, 2024
landry benjamin
sold (taxes)
-8,493
6.5333
-1,300
general counsel
Jun 03, 2024
alger jason
sold (taxes)
-8,088
6.5333
-1,238
chief financial officer
Jun 03, 2024
lesueur daniel
sold (taxes)
-12,236
6.5333
-1,873
chief operating officer
Jun 03, 2024
llewelyn linda
sold (taxes)
-11,211
6.5333
-1,716
chief people officer
Jun 03, 2024
freeman kevin lee
sold (taxes)
-19,279
6.5333
-2,951
chief commercial officer
Jun 03, 2024
burton daniel d.
sold (taxes)
-29,020
6.5333
-4,442
chief executive officer
May 31, 2024
landry benjamin
sold
-83,132
6.6099
-12,577
general counsel

1–10 of 50

Which funds bought or sold HCAT recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-4.17
-122,628
432,824
-%
May 16, 2024
Beacon Capital Management, LLC
sold off
-100
-3,380
-
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-24.15
-605,445
974,653
-%
May 16, 2024
Virtus Investment Advisers, Inc.
new
-
115,186
115,186
0.08%
May 16, 2024
B. Riley Wealth Advisors, Inc.
added
75.00
14,664
33,718
-%
May 16, 2024
COMERICA BANK
reduced
-61.71
-9,527
4,307
-%
May 15, 2024
DEUTSCHE BANK AG\
added
0.41
-351,405
1,563,990
-%
May 15, 2024
Lido Advisors, LLC
new
-
297,488
297,488
-%
May 15, 2024
Royal Bank of Canada
reduced
-6.71
-513,000
1,610,000
-%
May 15, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
reduced
-4.14
-171,174
605,231
-%

1–10 of 43

Are Funds Buying or Selling HCAT?

Are funds buying HCAT calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own HCAT
No. of Funds

Unveiling Health Catalyst Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
point72 asset management, l.p.
7.2%
4,157,366
SC 13G/A
Feb 13, 2024
vanguard group inc
9.57%
5,507,972
SC 13G/A
Feb 08, 2024
wellington management group llp
5.58%
3,213,413
SC 13G
Jan 24, 2024
blackrock inc.
9.2%
5,318,571
SC 13G/A
Jul 27, 2023
point72 asset management, l.p.
5.0%
2,824,198
SC 13G
Feb 14, 2023
alliancebernstein l.p.
0.2%
134,154
SC 13G/A
Feb 14, 2023
point72 asset management, l.p.
2.9%
1,566,000
SC 13G/A
Feb 13, 2023
capital research global investors
1.0%
568,785
SC 13G/A
Feb 09, 2023
vanguard group inc
11.09%
6,069,528
SC 13G/A
Feb 06, 2023
wellington management group llp
2.53%
1,385,432
SC 13G/A

Recent SEC filings of Health Catalyst Inc

View All Filings
Date Filed Form Type Document
Jun 12, 2024
144
Notice of Insider Sale Intent
Jun 12, 2024
4
Insider Trading
Jun 12, 2024
4
Insider Trading
Jun 12, 2024
4
Insider Trading
Jun 11, 2024
144
Notice of Insider Sale Intent
Jun 06, 2024
144
Notice of Insider Sale Intent
Jun 06, 2024
144
Notice of Insider Sale Intent
Jun 06, 2024
D
D
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading

Peers (Alternatives to Health Catalyst Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
457.7B
379.5B
-3.22% 8.59%
29.8
1.21
12.96% -25.81%
94.9B
206.0B
-3.57% 26.64%
24.62
0.46
12.55% -43.95%
89.3B
66.7B
6.37% 20.20%
16.32
1.34
9.59% -4.59%
76.6B
360.9B
8.98% -8.43%
10.46
0.21
9.07% 78.83%
36.8B
155.5B
-10.29% 6.67%
13.46
0.24
6.34% 84.42%
12.6B
14.7B
5.13% 28.66%
15.48
0.86
7.99% 19.23%
12.5B
12.3B
3.74% 45.80%
15.28
1.01
5.77% 58.74%
MID-CAP
8.1B
2.3B
-5.45% -0.01%
28.7
3.55
5.96% 18.29%
6.2B
3.0B
-7.01% -9.23%
-544.54
2.06
10.92% -104.06%
2.2B
1.5B
-5.59% 23.35%
34.9
1.5
19.34% 40.15%
2.0B
3.5B
-13.69% -50.16%
14.21
0.59
-27.67% -62.40%
SMALL-CAP
1.9B
1.1B
5.75% 24.78%
28.96
1.75
11.45% 30.74%
1.3B
3.0B
-6.99% 58.71%
-7.38
0.42
4.98% 4.88%
53.4M
-
-1.46% -24.54%
-3.54
-
- -1.05%
20.7M
21.6M
-7.10% 23.86%
40.75
0.96
9.04% -57.88%

Health Catalyst Inc News

Latest updates
Defense World10 hours ago

Health Catalyst Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-0.5%74,72375,08473,77373,21373,86869,16268,35470,63368,08764,71661,73759,62755,84653,27947,19143,25945,11643,50139,42336,80435,213
Operating Expenses-6.8%59,01863,29356,56668,39370,47867,80177,73569,21858,43875,60470,90061,89352,82565,67346,29735,77039,15335,49641,52728,45728,981
  S&GA Expenses10.3%19,05817,27115,08416,39718,56920,37325,40120,92220,81821,86320,80816,70515,65114,79314,62912,50213,48711,70514,72110,38510,473
  R&D Expenses-26.7%14,87120,28817,66717,59017,08219,61420,77018,14817,14817,47916,38514,52414,34514,97813,39012,06113,08813,04313,4779,71010,022
Income Taxes-21.0%11314359.0085.0069.0059.00156-944-3,551-149-6,658-192101-3.0014.004.00-1,20099.0021.0011.0011.00
Net Income32.1%-20,587-30,312-22,032-32,613-33,190-35,782-45,735-33,428-22,458-48,992-40,014-35,834-28,370-43,018-27,326-27,183-17,490-14,266-21,416-10,694-13,720
Net Income Margin10.9%-0.36*-0.40*-0.43*-0.52*-0.53*-0.50*-0.55*-0.55*-0.58*-0.63*-0.64*----------
Free Cashflow152.1%10,058-19,2962,966-11,981-6,005-15,236-13,225-9,778802-10,398-7,049----------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22018Q4
Assets-1.0%695702713723752752776811825832846563571578571466309302320140111
  Current Assets1.0%39739340841143542844346548250851532132533032339725026428095.0067.00
    Cash Equivalents89.5%20110695.0011613311612417719819327620513392.0011110461.0018.0052.0021.0028.00
  Net PPE-3.9%25.0026.0026.0026.0026.0026.0025.0027.0025.0023.0021.0020.0019.0013.005.004.004.004.004.004.005.00
  Goodwill0%1911915.0018618618618618618017017062.0010810810818.0018.004.004.00--
Liabilities0.9%33833533133334732733634234431029628730230227123210510211311276.00
  Current Liabilities3.6%92.0089.0084.0087.0010283.0091.0090.0093.0093.0026325525988.0066.0050.0050.0048.0053.0051.0042.00
  Long Term Debt0.2%228228228227227227226226225181---16916616348.0048.0048.0048.0019.00
    LT Debt, Current---------------------1.00
    LT Debt, Non Current0.2%228228228227227227226226225181---16916616348.0048.0048.0048.0019.00
Shareholder's Equity-2.6%357367382390405425440469481522549276269276300234204201207--
  Retained Earnings-1.8%-1,137-1,117-1,086-1,064-1,032-999-963-917-884-878-829-789-754-725-682-655-628-610-596-557-374
  Additional Paid-In Capital-------1,4041,3871,3651,4011,3791,0661,0231,002982889832811803--
Shares Outstanding1.1%59.0058.0057.0057.0055.0055.0054.0053.0053.0047.0046.00----------
Float----688---783---2,500---946-----
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations153.9%10,266-19,0413,115-11,574-5,580-14,821-12,031-9,5761,158-9,775-5,360-4,845-3,143-4,141-4,487-751-16,769-13,061-5,482-8,417-5,224
  Share Based Compensation-16.7%10,83813,01114,23214,62913,88418,74817,30417,93218,12016,42117,48717,72713,51010,6749,4969,0468,7414,8169,9741,3981,656
Cashflow From Investing180.7%83,98429,917-24,858-7,41522,6496,256-33,182-13,7511,656-76,683-172,79472,42337,376-21,905-3,976-106,83050,146-22,070-157,318-1,558-28,656
Cashflow From Financing118.5%8633951,0401,20293.00637-7,5391,9012,3883,916248,8334,8896,4466,74015,503150,7799,5871,098194,040-1,41437,657
  Buy Backs-----1,808-8,393--------------
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

HCAT Income Statement

2024-03-31
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:  
Total revenue[1]$ 74,723$ 73,868
Cost of revenue, excluding depreciation and amortization:  
Total cost of revenue, excluding depreciation and amortization38,51738,304
Operating expenses:  
Sales and marketing19,05818,569
Research and development14,87117,082
General and administrative14,56423,833
Depreciation and amortization10,52510,994
Total operating expenses59,01870,478
Loss from operations(22,812)(34,914)
Interest and other income, net2,3381,793
Loss before income taxes(20,474)(33,121)
Income tax provision11369
Net loss$ (20,587)$ (33,190)
Net loss per share, basic (in USD per share)$ (0.35)$ (0.60)
Net loss per share, diluted (in USD per share)$ (0.35)$ (0.60)
Weighted-average shares outstanding used in calculating net loss per share, basic (in shares)58,591,51455,484,835
Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares)58,591,51455,484,835
Technology  
Revenue:  
Total revenue[1]$ 46,966$ 47,186
Cost of revenue, excluding depreciation and amortization:  
Total cost of revenue, excluding depreciation and amortization15,31514,727
Professional services  
Revenue:  
Total revenue[1]27,75726,682
Cost of revenue, excluding depreciation and amortization:  
Total cost of revenue, excluding depreciation and amortization$ 23,202$ 23,577
[1]Includes amounts attributable to related party transactions. See Note 17 for further details.

HCAT Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 201,370$ 106,276
Short-term investments126,415211,452
Accounts receivable, net[1]53,87460,290
Prepaid expenses and other assets15,47715,379
Total current assets397,136393,397
Property and equipment, net24,69725,712
Intangible assets, net66,21773,384
Operating lease right-of-use assets12,00313,927
Goodwill190,652190,652
Other assets4,4074,742
Total assets695,112701,814
Current liabilities:  
Accounts payable5,6976,641
Accrued liabilities19,61423,282
Deferred revenue[1]63,55055,753
Operating lease liabilities3,3473,358
Total current liabilities92,20889,034
Convertible senior notes228,413228,034
Deferred revenue, net of current portion8177
Operating lease liabilities, net of current portion17,11217,676
Other liabilities8874
Total liabilities337,902334,895
Commitments and contingencies (Note 15)
Stockholders’ equity:  
Preferred stock, $0.001 par value per share; 25,000,000 shares authorized and no shares issued and outstanding as of March 31, 2024 and December 31, 202300
Common stock, $0.001 par value per share, and additional paid-in capital; 500,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 58,956,132 and 58,295,491 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively1,495,0911,484,056
Accumulated deficit(1,137,757)(1,117,170)
Accumulated other comprehensive income (loss)(124)33
Total stockholders’ equity357,210366,919
Total liabilities and stockholders’ equity$ 695,112$ 701,814
[1]Includes amounts attributable to related party transactions. See Note 17 for further details.
HCAT
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
 CEO
 WEBSITEhealthcatalyst.com
 INDUSTRYHealthcare Plans
 EMPLOYEES1200

Health Catalyst Inc Frequently Asked Questions


What is the ticker symbol for Health Catalyst Inc? What does HCAT stand for in stocks?

HCAT is the stock ticker symbol of Health Catalyst Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Health Catalyst Inc (HCAT)?

As of Thu Jun 13 2024, market cap of Health Catalyst Inc is 373.1 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HCAT stock?

You can check HCAT's fair value in chart for subscribers.

What is the fair value of HCAT stock?

You can check HCAT's fair value in chart for subscribers. The fair value of Health Catalyst Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Health Catalyst Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HCAT so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Health Catalyst Inc a good stock to buy?

The fair value guage provides a quick view whether HCAT is over valued or under valued. Whether Health Catalyst Inc is cheap or expensive depends on the assumptions which impact Health Catalyst Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HCAT.

What is Health Catalyst Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jun 13 2024, HCAT's PE ratio (Price to Earnings) is -3.54 and Price to Sales (PS) ratio is 1.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HCAT PE ratio will change depending on the future growth rate expectations of investors.